Davina Campbell

Davina Campbell

Auto-generated profile, based on publicly available information

Davina Campbell

Centers for Disease Control and Prevention

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Annals of Internal Medicine
Verified
Journal Article
Open access
SMSusannah L McKay
Susannah L McKay
FTFarrell A Tobolowsky
Farrell A Tobolowsky
EMErin D Moritz
Erin D Moritz
KHKelly M Hatfield
Kelly M Hatfield
ABAmelia Bhatnagar
Amelia Bhatnagar
PKPreeta K Kutty
Preeta K Kutty
It has been hoped that rapid SARS-CoV-2 antigen testing could reduce the tragic toll of COVID-19 in nursing homes. The performance of the BinaxNOW antigen test in a nursing home during an ongoing S... Visual Serial SARS-CoV-2 Rapid Antigen Testing During a Nursing Home Outbreak. It has been hoped that rapid SARS-CoV-2 antigen testing could reduce the tragic toll of COVID-19 in nursing h... Background: To address high COVID-19 burden in U.S. nursing homes, rapid SARS-CoV-2 antigen tests have been widely distributed in those facilities. However, performance data are lacking, especially...

29 April 2024 in American Journal of Infection Control
Verified
Journal Article
Open access
SBSandra N. Bulens
Sandra N. Bulens
DCDavina Campbell
Davina Campbell
SMSusannah L. McKay
Susannah L. McKay
NVNicholas Vlachos
Nicholas Vlachos
ABAlex Burgin
Alex Burgin
JLJoseph D. Lutgring
Joseph D. Lutgring
Understanding the epidemiology of carbapenem-resistant A. baumannii complex (CRAB) and the patients impacted is an important step toward informing better infection prevention and control practices and improving public health response. Active, population-based surveillance was conducted for CRAB in 9 U.S. sites from January 1 to December 31, 2019. Medical records were reviewed, isolates were collected and characterized including antimicrobial susceptibility testing and whole genome sequencing. Among 136 incident cases in 2019, 66 isolates were collected and characterized; 56.5% were from cases who were male, 54.5% were from persons of Black or African American race with non-Hispanic ethnicity, and the median age was 63.5 years. Most isolates, 77.2%, were isolated from urine, and 50.0% were collected in the outpatient setting; 72.7% of isolates harbored an acquired carbapenemase gene (aCP), predominantly blaOXA-23 or blaOXA-24/40; however, an isolate with blaNDM was identified. The antimicrobial agent with the most in vitro activity was cefiderocol (96.9% of isolates were susceptible). Our surveillance found that CRAB isolates in the U.S. commonly harbor an aCP, have an antimicrobial susceptibility profile that is defined as difficult-to-treat resistance, and epidemiologically are similar regardless of the presence of an aCP.

6 November 2024 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
AKAlyssa G. Kent
Alyssa G. Kent
LSLori M. Spicer
Lori M. Spicer
DCDavina Campbell
Davina Campbell
EBErin Breaker
Erin Breaker
GMGillian A. McAllister
Gillian A. McAllister
AGAmy S. Gargis
Amy S. Gargis
Enterococcus faecalis and Enterococcus faecium are frequent causes of healthcare-associated infections. Antimicrobial-resistant enterococci pose a serious public health threat, particularly vancomycin-resistant enterococci (VRE), for which treatment options are limited. The Centers for Disease Control and Prevention’s Division of Healthcare Quality Promotion Sentinel Surveillance system conducted surveillance from 2018 to 2019 to evaluate antimicrobial susceptibility profiles and molecular epidemiology of 205 E. faecalis and 180 E. faecium clinical isolates collected from nine geographically diverse sites in the United States. Whole genome sequencing revealed diverse genetic lineages, with no single sequence type accounting for more than 15% of E. faecalis or E. faecium . Phylogenetic analysis distinguished E. faecium from 19 E. lactis (previously known as E. faecium clade B). Resistance to vancomycin was 78.3% among E. faecium , 7.8% among E. faecalis , and did not occur among E. lactis isolates. Resistance to daptomycin and linezolid was rare: E. faecium (5.6%, 0.6%, respectively), E. faecalis (2%, 2%), and E. lactis (5.3%, 0%). All VRE harbored the vanA gene. Three of the seven isolates that were not susceptible to linezolid harbored optrA , one chromosomally located and two on linear plasmids that shared a conserved backbone with other multidrug-resistant conjugative linear plasmids. One of these isolates contained optrA and vanA co-localized on the linear plasmid. By screening all enterococci, 20% of E. faecium were predicted to harbor linear plasmids, whereas none were predicted among E. faecalis or E. lactis . Continued surveillance is needed to assess the future emergence and spread of antimicrobial resistance by linear plasmids and other mechanisms. IMPORTANCE: This work confirms prior reports of E. faecium showing higher levels of resistance to more antibiotics than E. faecalis and identifies that diverse sequence types are contributing to enterococcal infections in the United States. All VRE harbored the vanA gene. We present the first report of the linezolid resistance gene optrA on linear plasmids in the United States, one of which co-carried a vanA cassette. Additional studies integrating epidemiological, antimicrobial susceptibility, and genomic methods to characterize mechanisms of resistance, including the role of linear plasmids, will be critical to understanding the changing landscape of enterococci in the United States.

6 October 2026 in Antimicrobial Stewardship & Healthcare Epidemiology
Verified
Journal Article
Open access
PDF file
JBJoshua M. Brandenburg
Joshua M. Brandenburg
LCLatasha Curtis
Latasha Curtis
RRRuben E. Raymond
Ruben E. Raymond
UAUzma Ansari
Uzma Ansari
DCDavina E. Campbell
Davina E. Campbell
HGHeather N. Grome
Heather N. Grome
Population-based surveillance of urinary Escherichia coli was conducted in three U.S. counties. Findings included high incidence among females and older adults, resistance to recommended urinary tract infection treatments, and O serotypes common among invasive disease. The study emphasizes the value of understanding the epidemiology and resistance profiles to guide treatment.